Take­da adds one more late-stage treat­ment to its grow­ing ros­ter of celi­ac drugs

What­ev­er hap­pens with Take­da’s de­ter­mined cam­paign to tack­le celi­ac dis­ease from all sides, no one will ever be able to fault them for a lack …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.